Global Palmer Hyperhidrosis Treatment Market: Overview

Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe. The condition begins in childhood and may worsen with time. The condition is not life-threatening, but it affects the quality of life individuals. Persons affected with the condition may become self-conscious and socially withdrawn, leading to depression. Palmer hyperhidrosis may be caused due to genetic influence or as a result of some medical conditions or reaction to medication. The condition is usually diagnosed with the thermoregulatory sweat test. In the test, a powder sensitive to moisture is applied to the skin, which changes color if excessive sweating occurs at room temperature.  

Global Palmer Hyperhidrosis Treatment Market: Key Trends

The palmer hyperhidrosis treatment market is expected to expand at a rapid pace. A rise in the prevalence of hyperhidrosis, increased R&D spending, rich product pipeline, and increase in awareness regarding the condition are major factors expected to drive the global palmer hyperhidrosis treatment market. However, lack of permanent treatment options may act as restraints for the growth of the global palmer hyperhidrosis treatment market.

Global Palmer Hyperhidrosis Treatment Market: Segmentation

The global palmer hyperhidrosis treatment market can be segmented based on type, treatment, end-user, and region. In terms of type, the market can be classified into primary focal hyperhidrosis and secondary generalized hyperhidrosis. Primary focal hyperhidrosis is excessive sweating that is not caused by any medical conditions or medications. It usually begins in childhood. Secondary generalized hyperhidrosis is caused by medical conditions or side effects of certain medications. The primary focal hyperhidrosis segment held a prominent share of the market in 2017 and is expected to maintain its leading position during the forecast period.  Based on treatment, the global palmer hyperhidrosis treatment market can be divided into topical treatments, surgical treatments, iontophoresis, botulinum toxin A, systemic treatments, and others. The surgical treatments segment dominated the market in 2017, due to high acceptance and success rates of minimally invasive surgical procedures for the treatment of palmer hyperhidrosis in developed countries. According to an article published by NCBI, Endoscopic Thoracic Sympathectomy (ETS) is a widely accepted, safer, and more effective method for the treatment of palmer hyperhidrosis with comparatively higher success rates. The segment is expected to continue to dominate the market from 2018 to 2026. In terms of end-user, the market can be divide into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2017, due to high preference for hospitals for surgical treatments. This segment is expected to dominate the market during forecast period.

Global Palmer Hyperhidrosis Treatment Market: Regional Analysis

In terms of region, the global palmer hyperhidrosis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017, due to high prevalence of palmer hyperhidrosis in the region and rise in awareness regarding the condition. According to the Archives of Dermatological Research, the prevalence of hyperhidrosis is 4.8% i.e.  approximately 15.3 million people in the U.S. The market in Asia Pacific is anticipated to expand at a rapid CAGR, owing to a rise in awareness, increase in per capita income, and improvement in health care infrastructure.

Global Palmer Hyperhidrosis Treatment Market: Competitive Landscape

Major players operating in the Palmer Hyperhidrosis Treatment Market include GlaxoSmithKline plc., Ulthera, Inc., TheraVida, Dermira, Inc., Brickell Biotech, Inc., Dr. August Wolff GmbH & Co., Revance Therapeutics, Inc., Allergan, and Miramar Labs, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.